Varian Medical Systems, Inc designs, manufactures, sells, and services medical devices and software products for treating cancer and other medical conditions worldwide. It operates through two segments, Oncology Systems and Proton Solutions. The Oncology Systems segment offers hardware and software products for treating cancer with radiotherapy, fixed field intensity-modulated radiation therapy, image-guided radiation therapy, volumetric modulated arc therapy, stereotactic radiosurgery, stereotactic body radiotherapy, and brachytherapy, as well as related quality assurance equipment.
Read More…
Industry, Sector and Symbol
Industry Electromedical equipment
Sub-IndustryHealth Care Equipment
SectorMedical
Phone650-493-4000
Debt
Price-To-Earnings
Sales & Book Value
Annual Sales$3.23 billion
Profitability
Miscellaneous
Employees10,062
Next Earnings Date4/22/2020 (Estimated)
OptionableOptionable
Varian Medical Systems (NYSE:VAR) Frequently Asked Questions
What is Varian Medical Systems' stock symbol?
Varian Medical Systems trades on the New York Stock Exchange (NYSE) under the ticker symbol "VAR."
How were Varian Medical Systems' earnings last quarter?
Varian Medical Systems, Inc. (NYSE:VAR) issued its quarterly earnings data on Wednesday, January, 29th. The medical equipment provider reported $1.16 earnings per share for the quarter, missing analysts' consensus estimates of $1.21 by $0.05. The medical equipment provider had revenue of $828.90 million for the quarter, compared to the consensus estimate of $829.36 million. Varian Medical Systems had a return on equity of 24.40% and a net margin of 8.92%. The company's revenue was up 11.9% on a year-over-year basis. During the same quarter in the prior year, the firm earned $1.06 EPS. View Varian Medical Systems' Earnings History.
When is Varian Medical Systems' next earnings date?
What guidance has Varian Medical Systems issued on next quarter's earnings?
Varian Medical Systems updated its FY20 earnings guidance on Wednesday, January, 29th. The company provided earnings per share guidance of $5.30-5.45 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $5.40.
What price target have analysts set for VAR?
7 Wall Street analysts have issued 12 month price targets for Varian Medical Systems' stock. Their forecasts range from $157.00 to $171.00. On average, they expect Varian Medical Systems' stock price to reach $163.29 in the next year. This suggests a possible upside of 23.7% from the stock's current price. View Analyst Price Targets for Varian Medical Systems.
What is the consensus analysts' recommendation for Varian Medical Systems?
7 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Varian Medical Systems in the last year. There are currently 7 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Varian Medical Systems.
What are Wall Street analysts saying about Varian Medical Systems stock?
Here are some recent quotes from research analysts about Varian Medical Systems stock:
- 1. According to Zacks Investment Research, "Varian exited the fiscal first quarter on a weak note. However, the company continues to gain from its core Oncology Systems segment, which saw solid overseas growth, especially in EMEA and China. In fact, management foresees tremendous opportunities in China owing to the recent tariff exclusions. Gross orders surged in the quarter. Management is optimistic about the recently-closed acquisitions of CyberHeart, Cancer Treatment Services International, Endocare and Alicon. Expansion in gross margin is an added positive. Varian retained its outlook for fiscal 2020. On the flip side, the Proton Solutions unit was weak in the quarter. Moreover, Varian saw some softness in orders in Japan. Reflective of these, the stock has underperformed the industry in a year’s time. The stock is overvalued at the moment." (2/3/2020)
- 2. Barrington Research analysts commented, "We strongly suspect that radiation that is delivered via the Ethos system will receive very high marks from both clinicians and patients alike. Ethos currently has its CE Mark while a 510(k) regulatory clearance in the U.S. is still pending." (9/23/2019)
Has Varian Medical Systems been receiving favorable news coverage?
Press coverage about VAR stock has been trending very negative recently, according to InfoTrie Sentiment Analysis. The research group identifies positive and negative media coverage by reviewing more than six thousand news and blog sources in real-time. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Varian Medical Systems earned a media sentiment score of -3.0 on InfoTrie's scale. They also assigned news coverage about the medical equipment provider a news buzz of 10.0 out of 10, meaning that recent media coverage is extremely likely to have an impact on the company's share price in the near future. View News Stories for Varian Medical Systems.
Are investors shorting Varian Medical Systems?
Varian Medical Systems saw a decline in short interest during the month of January. As of January 15th, there was short interest totalling 1,660,000 shares, a decline of 15.7% from the December 31st total of 1,970,000 shares. Based on an average daily trading volume, of 627,300 shares, the days-to-cover ratio is presently 2.6 days. Currently, 1.8% of the company's stock are short sold. View Varian Medical Systems' Current Options Chain.
Who are some of Varian Medical Systems' key competitors?
Some companies that are related to Varian Medical Systems include Abbott Laboratories (ABT), Medtronic (MDT), Stryker (SYK), Intuitive Surgical (ISRG), Becton Dickinson and (BDX), Boston Scientific (BSX), Edwards Lifesciences (EW), Baxter International (BAX), DexCom (DXCM), ResMed (RMD), IDEXX Laboratories (IDXX), Teleflex (TFX), Steris (STE), Hologic (HOLX) and Insulet (PODD).
What other stocks do shareholders of Varian Medical Systems own?
Who are Varian Medical Systems' key executives?
Varian Medical Systems' management team includes the folowing people:
- Mr. Dow R. Wilson, Pres, CEO & Director (Age 60)
- Mr. Gary E. Bischoping Jr., Sr. VP of Fin. & CFO (Age 51)
- Mr. John W. Kuo, Sr. VP, Gen. Counsel & Corp. Sec. (Age 56)
- Ms. Kolleen T. Kennedy, Chief Growth Officer & Pres of Proton Solutions (Age 60)
- Mr. Kevin O'Reilly, Sr. VP of Global Operations
Who are Varian Medical Systems' major shareholders?
Varian Medical Systems' stock is owned by a number of of retail and institutional investors. Top institutional shareholders include State Street Corp (4.64%), Loomis Sayles & Co. L P (3.61%), Fiera Capital Corp (3.56%), Janus Henderson Group PLC (2.40%), Geode Capital Management LLC (1.52%) and First Eagle Investment Management LLC (1.46%). Company insiders that own Varian Medical Systems stock include Christopher A Toth, David J Illingworth, Dow R Wilson, Gary E Bischoping Jr, John W Kuo, Kolleen T Kennedy, Magnus Momsen, R Andrew Eckert and Timothy E Guertin. View Institutional Ownership Trends for Varian Medical Systems.
Which major investors are selling Varian Medical Systems stock?
VAR stock was sold by a variety of institutional investors in the last quarter, including Loomis Sayles & Co. L P, AJO LP, Nuance Investments LLC, Bank of America Corp DE, Oakbrook Investments LLC, Schroder Investment Management Group, AQR Capital Management LLC and Great West Life Assurance Co. Can. Company insiders that have sold Varian Medical Systems company stock in the last year include Christopher A Toth, Dow R Wilson, Gary E Bischoping Jr, John W Kuo, Kolleen T Kennedy, Magnus Momsen, R Andrew Eckert and Timothy E Guertin. View Insider Buying and Selling for Varian Medical Systems.
Which major investors are buying Varian Medical Systems stock?
VAR stock was acquired by a variety of institutional investors in the last quarter, including Marshall Wace North America L.P., Fiera Capital Corp, Los Angeles Capital Management & Equity Research Inc., Madison Asset Management LLC, York Capital Management Global Advisors LLC, Skandinaviska Enskilda Banken AB publ , Renaissance Technologies LLC and Banco Santander S.A.. View Insider Buying and Selling for Varian Medical Systems.
How do I buy shares of Varian Medical Systems?
Shares of VAR can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.
What is Varian Medical Systems' stock price today?
One share of VAR stock can currently be purchased for approximately $131.98.
How big of a company is Varian Medical Systems?
Varian Medical Systems has a market capitalization of $11.97 billion and generates $3.23 billion in revenue each year. The medical equipment provider earns $291.90 million in net income (profit) each year or $4.63 on an earnings per share basis. Varian Medical Systems employs 10,062 workers across the globe.View Additional Information About Varian Medical Systems.
What is Varian Medical Systems' official website?
How can I contact Varian Medical Systems?
Varian Medical Systems' mailing address is 3100 Hansen Way, Palo Alto CA, 94304. The medical equipment provider can be reached via phone at 650-493-4000 or via email at [email protected]
MarketBeat Community Rating for Varian Medical Systems (NYSE VAR)
MarketBeat's community ratings are surveys of what our community members think about Varian Medical Systems and other stocks. Vote "Outperform" if you believe VAR will outperform the S&P 500 over the long term. Vote "Underperform" if you believe VAR will underperform the S&P 500 over the long term. You may vote once every thirty days.
